Style | Citing Format |
---|---|
MLA | Safaeian L, Mirian M, Bahrizadeh S. "Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress." Archives of Physiology and Biochemistry, vol. 128, no. 6, 2022, pp. 1681-1686. |
APA | Safaeian L, Mirian M, Bahrizadeh S (2022). Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress. Archives of Physiology and Biochemistry, 128(6), 1681-1686. |
Chicago | Safaeian L, Mirian M, Bahrizadeh S. "Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress." Archives of Physiology and Biochemistry 128, no. 6 (2022): 1681-1686. |
Harvard | Safaeian L, Mirian M, Bahrizadeh S (2022) 'Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress', Archives of Physiology and Biochemistry, 128(6), pp. 1681-1686. |
Vancouver | Safaeian L, Mirian M, Bahrizadeh S. Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress. Archives of Physiology and Biochemistry. 2022;128(6):1681-1686. |
BibTex | @article{ author = {Safaeian L and Mirian M and Bahrizadeh S}, title = {Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress}, journal = {Archives of Physiology and Biochemistry}, volume = {128}, number = {6}, pages = {1681-1686}, year = {2022} } |
RIS | TY - JOUR AU - Safaeian L AU - Mirian M AU - Bahrizadeh S TI - Evolocumab, a Pcsk9 Inhibitor, Protects Human Endothelial Cells Against H2o2-Induced Oxidative Stress JO - Archives of Physiology and Biochemistry VL - 128 IS - 6 SP - 1681 EP - 1686 PY - 2022 ER - |